These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6117612)

  • 1. Acute and subchronic effects of bometolol on blood pressure in hypertensive rats.
    Watanabe TX; Watanabe Y; Hasegawa Y; Kudo Y; Kawashima K; Sokabe H
    J Pharmacobiodyn; 1981 Jul; 4(7):505-12. PubMed ID: 6117612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the adrenoceptor antagonistic and antihypertensive activity of oral amosulalol, a combined alpha- and beta-adrenoceptor antagonist, in hypertensive rats.
    Inagaki O; Sudoh K; Shibasaki M; Nakagawa C; Honda K
    J Cardiovasc Pharmacol; 1994 Nov; 24(5):794-802. PubMed ID: 7532758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antihypertensive effect of arotinolol (S-596), a new adrenergic beta blocking agent, on experimental hypertension].
    Hara Y; Nakahara H; Miyagishi A; Nakatani H
    Nihon Yakurigaku Zasshi; 1983 Aug; 82(2):103-16. PubMed ID: 6198264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carvedilol prevents severe hypertensive cardiomyopathy and remodeling.
    Barone FC; Campbell WG; Nelson AH; Feuerstein GZ
    J Hypertens; 1998 Jun; 16(6):871-84. PubMed ID: 9663928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive activity of bucumolol, a beta-adrenergic blocking agent, in spontaneously hypertensive rats.
    Miyamoto M; Koike H; Ito K; Nishino H
    J Pharmacobiodyn; 1981 Jul; 4(7):455-60. PubMed ID: 6117610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the antihypertensive properties of carvedilol, a compound with beta-blocking and vasodilating effects.
    Tanaka M; Masumura H; Tanaka S; Akashi A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S52-7. PubMed ID: 2454368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of prolonged treatment with adrenergic beta-receptor antagonists on blood pressure, cardiovascular design and reactivity in spontaneously hypertensive rats (SHR).
    Weiss L; Lundgren Y; Folkow B
    Acta Physiol Scand; 1974 Aug; 91(4):447-57. PubMed ID: 4154700
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of early carvedilol treatment and withdrawal on the development of hypertension and renal vascular narrowing.
    Kett MM; Denton KM; Boesen EI; Anderson WP
    Am J Hypertens; 2004 Feb; 17(2):161-6. PubMed ID: 14751659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
    Schiffrin EL; Turgeon A; Deng LY
    Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic carvedilol reduces mortality and renal damage in hypertensive stroke-prone rats.
    Barone FC; Nelson AH; Ohlstein EH; Willette RN; Sealey JE; Laragh JH; Campbell WG; Feuerstein GZ
    J Pharmacol Exp Ther; 1996 Nov; 279(2):948-55. PubMed ID: 8930204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic effects of a beta-adrenoceptor blocking drug, 4-[3-(tert-butylamino)-2-hydroxypropoxy]-N-methylisocarbostyril hydrochloride (N-696), in hypertensive rats.
    Kubota N; Kishi K; Sokabe H; Kawashima K; Ishii Y; Kawase S
    J Pharmacobiodyn; 1985 Feb; 8(2):134-41. PubMed ID: 2861268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of the antihypertensive action of hydralazine by timolol in spontaneously hypertensive rats.
    Scriabine A; Ludden CT; Bohidar NR
    Proc Soc Exp Biol Med; 1974 Jun; 146(2):509-12. PubMed ID: 4151781
    [No Abstract]   [Full Text] [Related]  

  • 13. Initial clinical experience with I.C.I. 66.082, a new beta-adrenergic blocking agent, in hypertension.
    Hansson L; Aberg H; Jameson S; Karlberg B; Malmcrona R
    Acta Med Scand; 1973 Dec; 194(6):549-50. PubMed ID: 4149321
    [No Abstract]   [Full Text] [Related]  

  • 14. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW; Laugerotte A; Wright JM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resting and postexercise hemodynamic effects of carvedilol, a beta-adrenergic blocker and precapillary vasodilator in hypertensive patients.
    Leonetti G; Sampieri L; Cuspidi C; Boselli L; Terzoli L; Rupoli L; Zanchetti A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S94-6. PubMed ID: 2454377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic effects of arotinolol (S-596) in spontaneously hypertensive rats.
    Kishi K; Kawashima K; Sokabe H; Saito K
    J Pharmacobiodyn; 1985 Jan; 8(1):50-5. PubMed ID: 2409263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular effects of tolamolol (UK-6558), a new beta-adrenoreceptor blocking drug, in pinealectomized hypertensive rats.
    Karppanen H; Lahovaara S; Mattila MJ
    Ann Med Exp Biol Fenn; 1973 Mar; 51(3):104-11. PubMed ID: 4149365
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of prolonged administration of indenolol in hypertensive rats.
    Kato H; Kurihara J; Takata Y; Kunugi H; Miyajima Y
    Arch Int Pharmacodyn Ther; 1983 Jul; 264(1):82-95. PubMed ID: 6138007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular and cardiac overexpression of endothelin-1 gene in one-kidney, one clip Goldblatt hypertensive rats but only in the late phase of two-kidney one clip Goldblatt hypertension.
    Sventek P; Turgeon A; García R; Schiffrin EL
    J Hypertens; 1996 Jan; 14(1):57-64. PubMed ID: 12013496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of beta-adrenergic blocking drugs in hypertensive rats.
    Sukamoto T; Shiono K; Watanabe TX; Sokabe H
    J Pharmacobiodyn; 1980 Jan; 3(1):1-10. PubMed ID: 6110712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.